[go: up one dir, main page]

NO20026130D0 - Sterkt immunostimulerende forbindelser fra mikroalger - Google Patents

Sterkt immunostimulerende forbindelser fra mikroalger

Info

Publication number
NO20026130D0
NO20026130D0 NO20026130A NO20026130A NO20026130D0 NO 20026130 D0 NO20026130 D0 NO 20026130D0 NO 20026130 A NO20026130 A NO 20026130A NO 20026130 A NO20026130 A NO 20026130A NO 20026130 D0 NO20026130 D0 NO 20026130D0
Authority
NO
Norway
Prior art keywords
microalgae
ethanol
strongly
extraction
immunostimulatory
Prior art date
Application number
NO20026130A
Other languages
English (en)
Other versions
NO329221B1 (no
NO20026130L (no
Inventor
David Pasco
Nirmal Pugh
Samir Ross
Mahmoud Elsohly
Original Assignee
Univ Mississippi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mississippi filed Critical Univ Mississippi
Publication of NO20026130D0 publication Critical patent/NO20026130D0/no
Publication of NO20026130L publication Critical patent/NO20026130L/no
Publication of NO329221B1 publication Critical patent/NO329221B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C07H1/08—Separation; Purification from natural products

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20026130A 2000-07-10 2002-12-19 Immunstimulerende preparat, anvendelse derav for fremstilling av et farmasoytisk preparat eller et kosttilskudd, farmasoytisk preparat og kosttilskudd, samt fremgangsmate for a oppna et preparat fra mikroalger. NO329221B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21700100P 2000-07-10 2000-07-10
PCT/US2001/021770 WO2002004000A1 (en) 2000-07-10 2001-07-10 Potent immunostimulants from microalgae

Publications (3)

Publication Number Publication Date
NO20026130D0 true NO20026130D0 (no) 2002-12-19
NO20026130L NO20026130L (no) 2003-03-10
NO329221B1 NO329221B1 (no) 2010-09-13

Family

ID=22809278

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20026130A NO329221B1 (no) 2000-07-10 2002-12-19 Immunstimulerende preparat, anvendelse derav for fremstilling av et farmasoytisk preparat eller et kosttilskudd, farmasoytisk preparat og kosttilskudd, samt fremgangsmate for a oppna et preparat fra mikroalger.

Country Status (20)

Country Link
US (2) US7205284B2 (no)
EP (1) EP1301191B1 (no)
JP (1) JP2004502737A (no)
KR (1) KR100831408B1 (no)
CN (2) CN1823848A (no)
AT (1) ATE311892T1 (no)
AU (2) AU2001273330C1 (no)
BR (1) BR0112424A (no)
CA (1) CA2412600C (no)
DE (1) DE60115654T2 (no)
DK (1) DK1301191T3 (no)
EA (1) EA006318B1 (no)
ES (1) ES2254451T3 (no)
IL (2) IL153503A0 (no)
MX (1) MXPA03000220A (no)
NO (1) NO329221B1 (no)
NZ (1) NZ523695A (no)
PL (1) PL203814B1 (no)
WO (1) WO2002004000A1 (no)
ZA (1) ZA200301050B (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2220800T3 (es) 2000-08-10 2004-12-16 Ocean Nutrition Canada Ltd. Preparaciones de chlorella que muestran propiedades inmunomoduladoras.
US6814961B1 (en) 2001-05-14 2004-11-09 Gitte S. Jensen Method for enhancing stem cell trafficking
JP4547911B2 (ja) 2002-02-01 2010-09-22 アリアド・ファーマシューティカルズ・インコーポレイテッド リン含有化合物およびその用途
FR2850277B1 (fr) * 2003-01-24 2005-04-08 Lanatech Composition comprenant un extrait d'aphanizomenon flos-aquae, son utilisation et sa preparation
NO320429B1 (no) * 2003-06-03 2005-12-05 Sinvent As Farmasoytisk blanding for forokning av motstanden mot sykdommer forarsaket av patogene mikroorganismer og anvendelse av glukan for fremstilling av en farmasoytisk blanding.
WO2006015115A2 (en) * 2004-07-30 2006-02-09 University Of Mississippi Potent immunostimulatory extracts from microalgae
RU2417093C2 (ru) * 2005-06-24 2011-04-27 Дезерт Лейк Текнолоджиз Очищенный компонент цианобактерий и способ применения
EP2032122B1 (en) * 2006-06-27 2016-04-13 Nutratec S.r.l. Extracts of aphanizomenon flos aquae (afa klamath), active compounds, and their uses
US20100003275A1 (en) * 2006-09-08 2010-01-07 The University Of Mississippi Immunostimulatory Composition comprising Lipoprotein in Microalgae Extract
US20110104189A1 (en) * 2008-05-06 2011-05-05 Ocean Nutrition Canada Limited Compositions obtained from chlorella extract having immunomodulating properties
US8308951B1 (en) 2010-04-06 2012-11-13 Heliae Development, Llc Extraction of proteins by a two solvent method
US8211308B2 (en) 2010-04-06 2012-07-03 Heliae Development, Llc Extraction of polar lipids by a two solvent method
US8211309B2 (en) 2010-04-06 2012-07-03 Heliae Development, Llc Extraction of proteins by a two solvent method
US8313648B2 (en) 2010-04-06 2012-11-20 Heliae Development, Llc Methods of and systems for producing biofuels from algal oil
US8273248B1 (en) 2010-04-06 2012-09-25 Heliae Development, Llc Extraction of neutral lipids by a two solvent method
CA2793695A1 (en) 2010-04-06 2011-10-13 Heliae Development, Llc Selective extraction of proteins from freshwater algae
US8202425B2 (en) 2010-04-06 2012-06-19 Heliae Development, Llc Extraction of neutral lipids by a two solvent method
US8115022B2 (en) 2010-04-06 2012-02-14 Heliae Development, Llc Methods of producing biofuels, chlorophylls and carotenoids
US8475660B2 (en) 2010-04-06 2013-07-02 Heliae Development, Llc Extraction of polar lipids by a two solvent method
WO2013075116A2 (en) 2011-11-17 2013-05-23 Heliae Development, Llc Omega 7 rich compositions and methods of isolating omega 7 fatty acids
US9217119B2 (en) 2011-11-28 2015-12-22 Southwest Research Institute Extraction of lipids from living cells utilizing liquid CO2
GB201208325D0 (en) * 2012-05-11 2012-06-27 Glycomar Ltd Saccharides
CN103463141A (zh) * 2013-09-22 2013-12-25 汤永强 一种小球藻喷剂
KR20150102308A (ko) 2014-02-28 2015-09-07 주식회사 코아로직 키터치 인지 가능한 터치패널
EP3034612A1 (en) 2014-12-16 2016-06-22 Greenaltech, S.L. Chitin and chitosan producing methods
JP6788882B2 (ja) * 2016-08-09 2020-11-25 イマジン・グローバル・ケア株式会社 自然免疫活性化作用を有する多糖類及び該多糖類を含有する自然免疫活性化剤又は飲食品
US20210283204A1 (en) * 2016-09-14 2021-09-16 Tes Holdings Co., Ltd. Lin28a ACTIVATOR AND USE THEREFOR
CN107625783A (zh) * 2017-08-09 2018-01-26 天津科技大学 硫酸酯化小球藻、螺旋藻复合多糖在免疫调节领域的应用
HUE063838T2 (hu) 2017-08-30 2024-02-28 Far East Bio Tec Co Ltd Cianobaktérium kivonatok, eljárások elõállításukra és felhasználásuk
CA3152782A1 (en) 2019-09-06 2021-03-11 BeautyPaste LLC Enhanced toothpaste and kits
CN110742900B (zh) * 2019-11-22 2022-06-14 湘潭大学 一种具有免疫调节活性的小球藻胞外多糖复合物及其制备方法和应用
CN111205376B (zh) * 2020-01-07 2021-11-02 华侨大学 一种疣荔枝螺多糖的制备方法及其应用
FR3121351B1 (fr) 2021-03-30 2024-03-08 Axeen Pharma Composition à base de spiruline et ses utilisations pour le renforcement de l’immunité
CN114195907B (zh) * 2021-10-20 2022-10-21 中国科学院南海海洋研究所 一种低分子量螺旋藻多糖及其制备方法和应用
CN114544527B (zh) * 2022-01-26 2023-05-02 浙江夸克生物科技有限公司 一种涎液化糖链抗原kl-6测定试剂盒及其制备方法
WO2023192811A1 (en) * 2022-03-30 2023-10-05 Om Biome, Inc. Method for tissue renewal using a microalgae-based biologically friendly base formula to reverse disease progression and foster tissue regeneration in conditions of mucosal injury and inflammation in the mouth and gastrointestinal tract

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3462412A (en) * 1966-04-20 1969-08-19 Tohoku Yakult Seizo Kk Process of producing an active substance for stimulating the function of the reticulo-endothelial system
JPS5896025A (ja) * 1981-12-02 1983-06-07 Kitasato Inst:The 新規生理活性物質ｃｈ−１およびその製造法
HU188311B (en) * 1982-03-04 1986-04-28 Szendrei,Kalman,Hu Process for producing biologically active polisaccharide concentrates and pharmaceutical compositions containing them as active agents
JPS6178729A (ja) * 1984-09-26 1986-04-22 Nisshin Oil Mills Ltd:The 免疫賦活化作用成分
JPS61167620A (ja) * 1985-01-19 1986-07-29 Toa Nenryo Kogyo Kk 多糖類を含んで成る抗癌剤
JPS61197525A (ja) * 1985-02-27 1986-09-01 Nisshin Oil Mills Ltd:The 抗腫瘍活性をもつ免疫賦活化剤
JPS6219528A (ja) * 1985-07-16 1987-01-28 Kurorera Kogyo Kk 制癌剤
CA1332650C (en) * 1987-06-18 1994-10-18 Kunitaka Hirose Polysaccharides and antiviral drugs containing the same as active ingredient
US5084386A (en) * 1989-03-31 1992-01-28 Sri International Production of beta-1,3-glucan in euglena
JPH06253881A (ja) * 1993-03-01 1994-09-13 Kurorera Kogyo Kk 糖タンパク複合体およびその製造方法
JP3020387B2 (ja) * 1993-07-27 2000-03-15 日石三菱株式会社 抗ウイルス物質
JPH0937265A (ja) * 1995-07-18 1997-02-07 Toshiba Corp 画像復号化装置
JPH09176022A (ja) * 1995-12-26 1997-07-08 Dainippon Ink & Chem Inc 腫瘍転移抑制剤
KR100555845B1 (ko) * 1996-01-26 2006-11-23 다카라 홀딩스 인크. 항암제

Also Published As

Publication number Publication date
KR20030069974A (ko) 2003-08-27
AU7333001A (en) 2002-01-21
IL153503A (en) 2008-11-26
US20070059317A1 (en) 2007-03-15
ZA200301050B (en) 2004-05-06
US20070264271A1 (en) 2007-11-15
US7205284B2 (en) 2007-04-17
ATE311892T1 (de) 2005-12-15
AU2001273330C1 (en) 2006-01-12
EA006318B1 (ru) 2005-10-27
JP2004502737A (ja) 2004-01-29
NO329221B1 (no) 2010-09-13
EP1301191B1 (en) 2005-12-07
CN1447695A (zh) 2003-10-08
EA200300123A1 (ru) 2004-02-26
NO20026130L (no) 2003-03-10
KR100831408B1 (ko) 2008-05-21
DE60115654D1 (de) 2006-01-12
CA2412600C (en) 2011-09-27
CA2412600A1 (en) 2002-01-17
DE60115654T2 (de) 2006-09-07
ES2254451T3 (es) 2006-06-16
CN1823848A (zh) 2006-08-30
AU2001273330B2 (en) 2005-07-28
CN1278691C (zh) 2006-10-11
DK1301191T3 (da) 2006-05-22
BR0112424A (pt) 2003-07-01
EP1301191A1 (en) 2003-04-16
EP1301191A4 (en) 2004-02-25
NZ523695A (en) 2004-07-30
PL359269A1 (en) 2004-08-23
WO2002004000A1 (en) 2002-01-17
MXPA03000220A (es) 2003-10-15
PL203814B1 (pl) 2009-11-30
IL153503A0 (en) 2003-07-06

Similar Documents

Publication Publication Date Title
NO20026130D0 (no) Sterkt immunostimulerende forbindelser fra mikroalger
JPS5461112A (en) Oncostatic polysaccharide* its preparation* and oncostatic drugs containing it as an effective component
WO2002023190A3 (en) Methods and products related to low molecular weight heparin
PT1096944E (pt) Extractos de zantoxilum bungeanum e formulacoes farmaceuticas e farmacologicas que os contem
WO2009060281A3 (en) Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties
WO2006015115A3 (en) Potent immunostimulatory extracts from microalgae
KR102354412B1 (ko) 혼합 꽃 추출물의 유산균 발효물을 유효성분으로 함유하는 화장료 조성물
Bi et al. Ginsenoside Rg1 enhanced immune responses to infectious bursal disease vaccine in chickens with oxidative stress induced by cyclophosphamide
EP1517694B1 (en) Plant extracts
ATE402158T1 (de) Flavonoid-derivat
DK0505519T3 (da) Kava-ekstrakt, fremgangsmåde til fremstilling af ekstrakten og anvendelse deraf
ATE213647T1 (de) Synthese eines typhusimpfstoffes unter verwendung eines polysaccharids aus einer pflanze oder einer frucht
CN101591228B (zh) 薁类化合物及其应用
ZA875175B (en) Inhibitor of protein synthesis,process for its isolation,its use and pharmaceutical compositions in which it is present
KR100311762B1 (ko) 항산화활성을가지는고로쇠나무추출물및이를이용한풀라반계화합물의제조방법
JP2003501044A5 (no)
JPS5394012A (en) Novel polysaccharide and its preparation
HUP0400647A2 (hu) Immunstimuláló aktivitással rendelkező poliszacharidszármazék, eljárás az előállítására és ezt tartalmazó gyógyszerkészítmények
GB1171783A (en) Pharmaceutical Preparations Containing a Vaccine.
JPS5394021A (en) Preparation of anti-tumor polysaccharide
JPS5394020A (en) Preparation of anti-tumor polysaccharide
JPS5394018A (en) Preparation of anti-tumor polysaccharide
YU38497A (sh) Derivati 1-karba-(detia)-cefalosporina, njihova proizvodnja, intermedijeri koji se koriste u toj proizvodnji, odgovarajući farmaceutski preparati i upotreba jedinjenja za proizvodnju farmaceutskih preparata
JPS5394013A (en) Preparation of anti-tumor polysaccharide
JPS53109925A (en) Preparation of anti-tumor polysaccharides

Legal Events

Date Code Title Description
MK1K Patent expired